Abstract:
Coronavirus disease 2019 (COVID-19) has been tied to many complications
such as hypercoagulability. It is more commonly seen in patients
admitted to intensive care unit. Herein, we report a case of an end
stage renal disease patient who developed recurrent arteriovenous graft
thrombosis in the setting of COVID-19.
Keywords: Arteriovenous graft thrombosis; COVID-19
associated coagulopathy; end-stage renal disease
Key Clinical Message :
Hypercoagulability is one of the common complications seen in COVID-19.
It can lead to multiple thromboembolic complications. Recurrent
arteriovenous graft thrombosis can be one of complications from this
pathophysiology.